Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 02/10/2026 BST			5-day change	1st Jan Change
10.50 ^USD	-6.75%		-10.79%	-33.04%

10-01	Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102	CI
10-01	Monte Rosa Therapeutics, Inc. - Special Call

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
MONTE ROSA THERAPEUTICS, INC.	896M	-	BB	-	-
WUXI APPTEC CO., LTD.	74.16B		AAA
ARGENX SE	57.39B		A
LONZA GROUP AG	47.64B		AAA
REVOLUTION MEDICINES, INC.	44.29B	-	B	-	-
IQVIA HOLDINGS INC.	42.5B		AAA
BEONE MEDICINES AG	40.71B		-
CELLTRION, INC.	30.97B		A
WUXI BIOLOGICS (CAYMAN) INC.	28.53B		AAA
BIONTECH SE	24.34B	-	-	-	-
INSMED INCORPORATED	24.27B	-	BBB	-	-
GENMAB A/S	20.32B		A
MEDPACE HOLDINGS, INC.	16.73B		BBB
PHARMAESSENTIA CORPORATION	15.16B		AA
ASCENDIS PHARMA A/S	14.96B	-	-	-	-
EUROFINS SCIENTIFIC SE	14.63B		AA
EXELIXIS, INC.	14.47B		BB
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	14.38B		AA
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	13.85B		AA
TEMPUS AI, INC.	13.83B		A		-
Average	27.7B		AA
Weighted average by Cap.			AA